Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Immunotherapy has raised high expectations in the treatment of virtually every cancer. Many current efforts are focused on ensuring the efficient delivery of active cytotoxic cells to tumors. It is assumed that, once these active cytotoxic cells are correctly engaged to cancer cells, they will unfai...

Descripción completa

Detalles Bibliográficos
Autores principales: Arenas, Enrique J., Martínez-Sabadell, Alex, Rius Ruiz, Irene, Román Alonso, Macarena, Escorihuela, Marta, Luque, Antonio, Fajardo, Carlos Alberto, Gros, Alena, Klein, Christian, Arribas, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902842/
https://www.ncbi.nlm.nih.gov/pubmed/33623012
http://dx.doi.org/10.1038/s41467-021-21445-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902842/
https://www.ncbi.nlm.nih.gov/pubmed/33623012
http://dx.doi.org/10.1038/s41467-021-21445-4

Ejemplares similares